Patents expiring in 2028

US 7446108

Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists

Neurocrine, Inc. · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446112

Modulators of muscarinic receptors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7445890

Ucp-2 promoter and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7446185

Her2/neu target antigen and use of same to stimulate an immune response

The Regents of the University of California · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7445794

Methods for treating human proliferative diseases, with a combination of fatty acid metabolism inhibitors and glycolytic inhibitors

The Regents of the University of Colorado · Granted Tue Nov 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449190

Assays for assembly of Ebola virus nucleocapsids

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449557

Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy

University of Connecticut Health Center · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449570

Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

PTC THERAPEUTICS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449202

Compositions and methods for prostate and kidney health and disorders, an herbal preparation

Integrated Chinese Medicine Holdings Ltd. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449323

Hemorrhagic feline calicivirus

The Regents of the University of California · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449458

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449201

Storage stable power compositions of interleukin-4 receptor

Nektar Therapeutics · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449192

Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction

The Regents of the University of Colorado · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449182

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449171

Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolic products

The Regents of the University of California · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7449444

Hydroxyethyl starch-containing polypeptide compositions

The Regents of the University of Colorado · Granted Tue Nov 11 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 06 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2008137828

MODÈLE DE MARQUEUR DE MATRICE ET PROCÉDÉS POUR ÉVALUER ET TRAITER L'ARTHRITE ET DES TROUBLES ASSOCIÉS

CENTOCOR INC [US] · Granted Thu Nov 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Nov 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452723

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452971

Compositions and methods for modifying toxic effects of proteinaceous compounds

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452995

Aryl aniline β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452964

Compositions and methods of use of targeting peptides against placenta and adipose tissues

The Board of Regents of the University of Texas System · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452898

Phosphonate compounds

The Regents of the University of California · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452887

Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof

Amphora Discovery Corporation · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452873

Inhibitors of GSK-3 and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452865

Antagonistic analogs of GH RH (2003)

United States of America by Dept of Veterans Affairs · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452861

Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

Theravance, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452866

Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1

Alseres Pharmaceuticals, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452879

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452538

Death domain containing receptor 4 antibodies and methods

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452679

Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof

Northwestern University · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452681

Diagnostic methods for the detection of autism spectrum disorder

The Regents of the University of California · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452548

Conjugated linoleic acid compositions

Aker Biomarine AS · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7452544

Bacteriocins and novel bacterial strains

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Nov 18 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 13 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7455833

Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7455845

Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure

The Regents of the University of Colorado · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7455964

Genes from the 20q13 amplicon and their uses

The Regents of the University of California · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7455994

Methods for producing Marburg virus proteins

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456180

Piperazine derivatives and their use as therapeutic agents

Xenon Pharmaceuticals Inc. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456190

Compositions useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456199

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456203

Muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456207

Vaginal pharmaceutical compositions and methods for preparing them

Teva Pharmaceuticals USA, Inc. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456297

Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456268

Materials and methods for inhibiting Wip1

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456222

Anti tubercular drug: compositions and methods

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7456162

Benzofuran derivatives, their production and use

Takeda Pharmaceutical Company Limited · Granted Tue Nov 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459426

Methods of using IL-1 antagonists to treat autoinflammatory disease

REGENERON PHARMACEUTICALS, INC. · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7459534

Inactivation resistant factor VIII

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Dec 02 2008 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2028 00:00:00 GMT+0000 (Coordinated Universal Time)